Last reviewed · How we verify

NCT05080595: TAP-LT

Transportation Assistance Program for Liver Transplant

ENROLLING BY INVITATION NA Last updated 10 May 2024
What this trial tests

NA trial testing Transportation assistance (Lyft rides) in Liver Transplantation in 60 participants. Enrolling by invitation.

Timeline
24 January 2022
Primary endpoint
27 November 2023
30 November 2024

Quick facts

Lead sponsorUniversity of Southern California
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingnone
Primary purposehealth services research
Enrollment60
Start date24 January 2022
Primary completion27 November 2023
Estimated completion30 November 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Southern California

Who can join

18 and older, any sex, with Liver Transplantation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We propose a rideshare-supported intervention that leverages a partnership with Lyft Health, a HIPAA-secured logistics solution that enables us to provide reliable and efficient transportation for patients. Lyft rides will be provided to patients for any transplant-related medical visits, including but not limited to clinic visits with transplant providers, laboratory testing, and imaging/procedural testing that need to be performed as part of the routine evaluation process and prior to waitlisting for transplant.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A pilot randomized controlled trial of a transportation assistance program in liver transplant (TAP-LT) candidates.
    Zhou K, Wong C, Almanza J, Chen A, et al · · 2026 · PMID 41705818 · DOI 10.1097/lvt.0000000000000832

Verify or expand the search:

Other recruiting trials for Liver Transplantation

Currently open trials in the same condition.

Other University of Southern California trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05080595.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing